QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Welcome Kelsi!
This week Kelsi Smith joined the Quantify team in Stockholm as Senior Project Leader.
Kelsi moved from Canada to Sweden 8 years ago to conduct RWE research using Swedish registers. Since then Kelsi has gained a PhD in epidemiology, neuroscience and genetics from Karolinska Institutet and also industry experience. Kelsi loves to work with varied data sets as she previously has combined register-based data, […]
Will you be attending ISPOR in Atlanta?
Quantify’s Kirk Geale, Emilie Toresson Grip & Puneet Kaushik will be on site and ready to connect.
Keep a lookout for booth #337 to have a chat and learn more about Quantify’s services and expertise, or get in touch now to schedule a meeting!
Make sure to drop by our booth and check out our poster presentations too.
See you there!
Curious about Finnish real-world data?
Finland, with its robust healthcare system and comprehensive data infrastructure, provides an ideal environment for conducting real-world evidence (RWE) studies.
In this context, let’s explore the distinctive features of Finnish real-world data (RWD) and how they can contribute towards high-impact research:
1. Wide Range Of Data Opportunities Using National Registries:
Researchers can explore a treasure trove of information, including nationwide primary care and specialty care, prescriptions, cause of death, sickness, and disability […]
Did you know Quantify is an ENCePP partner conducting PASS studies?
Since 2020, Quantify Research has been a proud partner to the European Medicines Agency-coordinated ENCePP (European Network for Centres of Pharmacoepidemiology and Pharmacovigilance) initiative.
This network brings together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe with the aim of conducting high quality, multi-center, independent Post Authorization Safety Studies (PASS) with a focus on observational research.
Quantify has executed a variety of imposed- and non-imposed PASS studies […]